Back to Search
Start Over
A Prospective Study of Neoadjuvant Gemcitabine Plus Nab-paclitaxel in Patients with Borderline-resectable Pancreatic Cancer.
- Source :
- Internal Medicine; 2023, Vol. 62 Issue 3, p327-334, 8p
- Publication Year :
- 2023
Details
- Language :
- English
- ISSN :
- 09182918
- Volume :
- 62
- Issue :
- 3
- Database :
- Complementary Index
- Journal :
- Internal Medicine
- Publication Type :
- Academic Journal
- Accession number :
- 161736600
- Full Text :
- https://doi.org/10.2169/internalmedicine.9504-22